Blotting techniques are increasingly gaining importance globally that is used to separate and identify the proteins. Blocking buffers are one of the techniques that are used for this purpose. Blocking buffers are composed of slat solutions which include tris-buffered saline (TBS; 50 mM Tris and 150 mM NaCl, pH 7.6) and phosphate-buffered saline (PBS; 140 mM NaCl, 10 mM phosphate buffer, and 3 mM KCl, pH 7.4).
Download the PDF Sample Report (Including FULL TOC, Graphs, and Tables) of this report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=glo...
Data Bridge Market Research analyses that the blocking buffers market is expected to undergo a CAGR of 5.00% during the forecast period of 2022 to 2029. “Salt Solution” dominates the end user segment of the blocking buffers market owing to the growing number of hospitals especially in the developing economies.
Blocking buffers are non-specific protein solutions that passively adsorbs to all remaining binding surfaces. Blocking buffers is a solution of irrelevant protein, mixture of proteins, or other compound that connects non-specifically to plate surfaces. The blocking buffers are composed of salt solutions and blocking agent.
In February 2021, in June 2019, Bio-Techne Corporation reached agreement to acquire B-MoGen Biotechnologies Inc. this acquisition would prove to be fruitful for the company to operate in the market in the long run.
In November 2019, Bio-Rad Laboratories, Inc. launched EveryBlot Blocking Buffer, a western blot blocking reagent that offers 5-minute blocking time and produces higher signal and lower background levels
Some of the major players operating in the blocking buffers market are:
Thermo Fisher Scientific Inc. (US)
LI-COR, Inc. (US)
Calbiotech, Inc. (US)
CANDOR Bioscience GmbH (Germany)
Bio-Rad Laboratories, Inc. (US)
Rockland Immunochemicals, Inc. (US)
Advansta Inc. (US)
CryoLife, Inc. (US)
LifeNet Health (US)
LeMaitre Vascular, Inc. (US)
Boston Scientific Corporation (US)
Hancock Jaffe Laboratories, Inc. (US)
KARL STORZ SE & Co. KG (Germany)
Getinge AB (Sweden)
Terumo Systems Corporation (Japan)
Novartis AG (Switzerland)
Pfizer Inc. (US)
Merck & Co., Inc. (Germany)
Novo Nordisk A/S (Denmark)
Amgen Inc. (US)
F. Hoffmann-La Roche Ltd (Switzerland)
Johnson & Johnson Services, Inc. (US)
GlaxoSmithKline plc (UK)
Bayer AG (Germany)
Bristol-Myers Squibb Company (US)
Bausch & Lomb Incorporated (US)
AbbVie Inc. (US)
View Detailed [email protected] https://www.databridgemarketresearch.com/reports/global-blocking-bu...
Global Blocking Buffers Market Scope
The blocking buffers market is segmented on the basis of composition, end-users and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
On the basis of composition, blocking buffers market is segmented into salt solution, detergent, and blocking agent.
Pharmaceutical and Biotechnology Companies and Contract Research Organisations
Research and Academic Laboratories
The end- users segment of blocking buffers market is divided into hospitals, clinical laboratories, pharmaceutical and biotechnology companies and contact research organizations, blood banks, research and academic laboratories, and others.
Quantitative Western Blot
Chemiluminescent Western Blots
In-Cell Western Assay
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation